Applied Genetic Technologies Corporation（AGTC）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · AGTC · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2022-06	2021-06	2020-06	2019-06	2018-06
Revenue
Revenue	$0.33M	$0.50M	$2.45M	$41.69M	$24.19M
Cost of Revenue	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Gross Profit	$0.33M	$0.50M	$2.45M	$41.69M	$24.19M
Gross Margin %(computed)	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Expenses
R&D Expenses	$49.52M	$44.40M	$35.78M	$33.18M	$32.18M
G&A Expenses	$16.98M	$14.55M	$13.62M	$12.86M	$14.39M
Total Operating Expenses	$66.50M	$58.95M	$49.40M	$46.04M	$46.57M
Operating Income	($66.27M)	($58.45M)	($46.94M)	($4.35M)	($22.38M)
Operating Margin %(computed)	—	—	—	-10.43%	-92.55%
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$2.67M	$1.51M	$0.00M	$0.00M	$0.00M
Income Before Tax	($68.75M)	($59.94M)	($45.81M)	($1.90M)	($21.21M)
Income Tax Expense	$2.67M	($2.11M)	$0.08M	$0.08M	$0.07M
Net Income	($71.42M)	($57.83M)	($45.89M)	($2.01M)	($21.30M)
Net Margin %(computed)	—	—	—	-4.81%	-88.07%
Per Share & EBITDA
EPS (Basic)	$-1.59	$-1.77	$-2.17	$-0.11	$-1.18
Wtd Avg Shares	45.03M	32.76M	21.10M	18.16M	18.11M
EBITDA	($64.76M)	($56.97M)	($46.94M)	($4.35M)	($20.05M)
EBITDA Margin %(computed)	—	—	—	-10.43%	-82.91%